A New Causal Rule Learning Approach to Interpretable Estimation of Heterogeneous Treatment Effect
用于可解释异质性处理效应估计的因果规则学习新方法AI 解读 ↓
本页整理公开书目信息,不生成学术质量评分。AI 解读根据题名及所注明的摘要或原文片段生成,未完成全文核验,可能有误;具体假设、证明与结论请核对原文。摘要保留来源文本,未经模型改写。
DOI 首次登记不等于接收或发表日期。部分更正、评论等条目没有独立摘要;缺少可靠材料时保留待补状态。
本页为预印本版本;arXiv 收录、作者填写的期刊信息以及作者既有发表经历,都不单独证明本篇已接收。作者发表记录按 OpenAlex 身份与完整姓名、本站覆盖期刊 ISSN 及正式卷期核对,只展示已核实例,档案仍可能误合并。
引用量采用 OpenAlex 单条关联记录,不合计多个记录;关联记录可能包含正式发表版本,不等于此版本单独引用。缺失不视为零,引用指标不代表论文质量。
关注作者按书目中的完整姓名匹配,同名和姓名变体需人工辨别。相关论文先按共享细分方向和具体方法排列,再参考通用方法与发表日期。
AI 根据所提供的论文材料归类:摘要直接研究异质性处理效应、亚组平均处理效应及其可解释估计,因此归入因果推断。
用于可解释异质性处理效应估计的因果规则学习新方法AI 解读 ↓
正在核对关联版本…
正在核对对应版本的资源…
Interpretability plays a crucial role in the application of statistical learning to estimate heterogeneous treatment effects (HTE) in complex diseases. In this study, we leverage a rule-based workflow, namely causal rule learning (CRL), to estimate and improve our understanding of HTE for atrial septal defect, addressing an overlooked question in the previous literature: what if an individual simultaneously belongs to multiple groups with different average treatment effects? The CRL process consists of three steps: rule discovery, which generates a set of causal rules with corresponding subgroup average treatment effects; rule selection, which identifies a subset of these rules to deconstruct individual-level treatment effects as a linear combination of subgroup-level effects; and rule analysis, which presents a detailed procedure for further analyzing each selected rule from multiple perspectives to identify the most promising rules for validation. Extensive simulation studies and real-world data analysis demonstrate that CRL outperforms other methods in providing interpretable estimates of HTE, especially when dealing with complex ground truth and sufficient sample sizes.